Thomas Stricker
Overview
Explore the profile of Thomas Stricker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
1006
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
De Bellis C, Vennam S, Eeles C, Rahimizadeh P, Cates J, Stricker T, et al.
Clin Cancer Res
. 2024 Nov;
31(1):205-216.
PMID: 39513940
Purpose: Desmoid tumors are bland fibroblastic tumors that do not metastasize but have a high rate of local recurrence. Previously published studies proposed two different transcriptomic signatures to predict relapse....
2.
Stricker T, Jain N, Ma E, Yu E, Wang R, Schuldt R, et al.
Oncologist
. 2024 Feb;
29(6):534-542.
PMID: 38417095
Background: A recent real-world study observed that 24% of patients with advanced non-small cell lung cancer (aNSCLC) with actionable driver oncogenes (ADOs) initiated nontargeted therapies before biomarker test results became...
3.
Allan M, Lievre M, Laurenson-Schafer H, De Barros S, Jinnai Y, Andrews S, et al.
Int J Equity Health
. 2023 May;
22(1):95.
PMID: 37198677
No abstract available.
4.
Allan M, Lievre M, Laurenson-Schafer H, De Barros S, Jinnai Y, Andrews S, et al.
Int J Equity Health
. 2022 Nov;
21(Suppl 3):167.
PMID: 36419127
In January 2020, SARS-CoV-2 virus was identified as a cause of an outbreak in China. The disease quickly spread worldwide, and the World Health Organization (WHO) declared the pandemic in...
5.
Yoneda Z, Anderson K, Ye F, Quintana J, ONeill M, Sims R, et al.
JAMA Cardiol
. 2022 May;
7(7):733-741.
PMID: 35544069
Importance: Patients with early-onset atrial fibrillation (AF) are enriched for rare variants in cardiomyopathy and arrhythmia genes. The clinical significance of these rare variants in patients with early-onset AF is...
6.
Sochacki A, Bejan C, Zhao S, Patel A, Kishtagari A, Spaulding T, et al.
Blood Adv
. 2022 Apr;
7(5):756-767.
PMID: 35420683
Treatment decisions in primary myelofibrosis (PMF) are guided by numerous prognostic systems. Patient-specific comorbidities have influence on treatment-related survival and are considered in clinical contexts but have not been routinely...
7.
LeNoue-Newton M, Chen S, Stricker T, Hyman D, Blauvelt N, Bedard P, et al.
Clin Cancer Res
. 2022 Feb;
28(10):2118-2130.
PMID: 35190802
Purpose: We wanted to determine the prognosis and the phenotypic characteristics of hormone receptor-positive advanced breast cancer tumors harboring an ERBB2 mutation in the absence of a HER2 amplification. Experimental...
8.
Stauffer K, Elion D, Cook R, Stricker T
Cancer Med
. 2021 Sep;
10(21):7692-7711.
PMID: 34581028
Background: Cancer resequencing studies have revealed epigenetic enzymes as common targets for recurrent mutations. The monomethyltransferase MLL3 is among the most recurrently mutated enzymes in ER+ breast cancer. The H3K4me1 ...
9.
Yoneda Z, Anderson K, Quintana J, ONeill M, Sims R, Glazer A, et al.
JAMA Cardiol
. 2021 Sep;
6(12):1371-1379.
PMID: 34495297
Importance: Early-onset atrial fibrillation (AF) can be the initial manifestation of a more serious underlying inherited cardiomyopathy or arrhythmia syndrome. Objective: To examine the results of genetic testing for early-onset...
10.
Jain N, Schmalz L, Cann C, Holland A, Osterman T, Lang K, et al.
Oncologist
. 2021 Aug;
26(11):e1962-e1970.
PMID: 34390291
Background: Over the past few years, tumor next-generation sequencing (NGS) panels have evolved in complexity and have changed from selected gene panels with a handful of genes to larger panels...